Sp436

PHAGE-SPECIFIC IMMUNITY IMPAIRS EFFICACY OF BACTERIOPHAGE TARGETING VANCOMYCIN RESISTANT ENTEROCOCCUS IN A MURINE MODEL.

Date

May 19, 2024

Presenters

Guangfu Li

Ipsita Mohanty

Rohit Loomba

University of California San Diego

Tracks

AASLD

Related Products

EXPLORING THE ROLE OF THE MICROBIOME IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND METABOLIC SYNDROME: PERSPECTIVES FROM RENOWNED EXPERTS

THE ROLE OF WESTERN DIET AND GUT MICROBIOTA IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): INSIGHTS INTO MEDIATORS AND THERAPEUTIC TARGETS

ALT, FIBROSCAN VCTE, AND FIBROSCAN CAP AS PREDICTIVE MARKERS OF RESMETIROM BIOPSY RESPONSE

INTRODUCTION. MAESTRO-NASH (NCT03900429) is an ongoing 54-month, randomized, double-blind, placebo-controlled Phase 3 trial evaluating the efficacy of resmetirom in patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and fibrosis…

ADVANCING MASS SPECTROMETRY INSIGHTS IN METABOLIC DISORDERS AND LIVER DISEASES